Cisen Pharmaceutical Co., Ltd. (SHA:603367)

Cisen Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 2, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	6,470	6,601	5,668	5,978	6,229	7,503
Market Cap Growth	5.67%	16.46%	-5.19%	-4.03%	-16.98%	9.03%
Enterprise Value	4,031	4,082	3,364	3,917	3,923	5,231
Last Close Price	14.29	13.99	11.77	12.16	12.41	14.54
PE Ratio	12.21	12.66	16.20	17.89	14.20	14.58
Forward PE	-	46.95	46.95	46.95	46.95	46.95
PS Ratio	1.52	1.48	1.39	1.58	1.70	1.82
PB Ratio	1.11	1.15	1.06	1.18	1.30	1.64
P/TBV Ratio	1.16	1.20	1.11	1.23	1.36	1.72
P/FCF Ratio	17.65	15.23	25.40	32.74	27.23	96.33
P/OCF Ratio	15.08	14.63	21.94	25.59	14.45	41.39
EV/Sales Ratio	0.95	0.92	0.83	1.03	1.07	1.27
EV/EBITDA Ratio	5.74	5.52	6.47	9.07	7.58	8.31
EV/EBIT Ratio	8.51	7.97	11.55	18.28	10.96	11.24
EV/FCF Ratio	11.00	9.41	15.08	21.45	17.15	67.16
Debt / Equity Ratio	0.01	0.03	0.03	0.03	0.07	0.02
Debt / EBITDA Ratio	0.11	0.23	0.30	0.33	0.64	0.16
Debt / FCF Ratio	0.22	0.39	0.71	0.79	1.44	1.28
Asset Turnover	0.59	0.63	0.62	0.60	0.63	0.76
Inventory Turnover	2.17	2.97	3.11	2.96	2.75	2.84
Quick Ratio	2.44	3.02	3.17	2.86	2.56	3.50
Current Ratio	3.20	3.63	3.70	3.40	3.08	4.27
Return on Equity (ROE)	9.29%	9.45%	6.77%	6.78%	9.33%	11.79%
Return on Assets (ROA)	4.07%	4.52%	2.76%	2.14%	3.82%	5.39%
Return on Capital (ROIC)	5.05%	5.59%	3.40%	2.59%	4.56%	6.59%
Return on Capital Employed (ROCE)	7.90%	8.60%	5.30%	4.20%	7.30%	10.00%
Earnings Yield	8.18%	7.90%	6.17%	5.59%	7.04%	6.86%
FCF Yield	5.66%	6.57%	3.94%	3.05%	3.67%	1.04%
Dividend Yield	3.08%	3.12%	2.85%	2.47%	2.06%	1.84%
Payout Ratio	38.03%	29.95%	39.87%	36.13%	63.81%	23.08%
Buyback Yield / Dilution	0.06%	0.25%	-0.65%	0.18%	-0.21%	0.50%
Total Shareholder Return	3.14%	3.37%	2.19%	2.64%	1.85%	2.34%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.